Officials have confirmed that a second clinical trial testing a Canadian-made vaccine against Ebola in humans began on Wednesday at the US National Institutes of Health (NIH). Known as VSV-ZEBOV, the experimental vaccine was developed by researchers at the Public Health Agency of Canada's National Microbiology Laboratory, and is licensed to NewLink Genetics Corp in the US state of Iowa. The latest trial involves trying two doses, a strategy known as ...
Read More
No comments:
Post a Comment